TSN the sustainable nutrition group ltd

ha-irinotecan phase 3 trial update , page-13

  1. 141 Posts.
    lightbulb Created with Sketch. 1
    41 point rise on the asx. 2c rise on the updated announcement day of the ph111 trials which was rated as market sensitive.

    frankly i dont think the market could give a brass razoo about the oncology side of things at this point in time.

    bring on the cash from fonda
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.